Pamela Ann Connealy insider trades
Open-market stock purchases and sales by Pamela Ann Connealy, Director at Orchestra BioMed Holdings, Inc, from SEC Form 4 filings since Jan 26, 2023.
Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -8%.
Get free alerts when Pamela Ann Connealy files a new trade →